JP2025505041A5 - - Google Patents
Info
- Publication number
- JP2025505041A5 JP2025505041A5 JP2024547679A JP2024547679A JP2025505041A5 JP 2025505041 A5 JP2025505041 A5 JP 2025505041A5 JP 2024547679 A JP2024547679 A JP 2024547679A JP 2024547679 A JP2024547679 A JP 2024547679A JP 2025505041 A5 JP2025505041 A5 JP 2025505041A5
- Authority
- JP
- Japan
- Prior art keywords
- subject
- pharmaceutical product
- cancer
- product according
- gene mutations
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202263268026P | 2022-02-15 | 2022-02-15 | |
| US63/268,026 | 2022-02-15 | ||
| PCT/EP2023/053555 WO2023156357A1 (en) | 2022-02-15 | 2023-02-14 | Methods of treating prostate cancer |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025505041A JP2025505041A (ja) | 2025-02-19 |
| JP2025505041A5 true JP2025505041A5 (https=) | 2026-02-20 |
Family
ID=85283519
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024547679A Withdrawn JP2025505041A (ja) | 2022-02-15 | 2023-02-14 | 前立腺癌を処置する方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20250134887A1 (https=) |
| EP (1) | EP4479053A1 (https=) |
| JP (1) | JP2025505041A (https=) |
| KR (1) | KR20240148418A (https=) |
| CN (1) | CN118829430A (https=) |
| AU (1) | AU2023220646A1 (https=) |
| CA (1) | CA3250763A1 (https=) |
| IL (1) | IL314798A (https=) |
| MX (1) | MX2024009923A (https=) |
| TW (1) | TW202400267A (https=) |
| WO (1) | WO2023156357A1 (https=) |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PL1633724T3 (pl) | 2003-03-12 | 2011-10-31 | Kudos Pharm Ltd | Pochodne ftalazynonu |
| US12280049B2 (en) * | 2020-08-04 | 2025-04-22 | Astrazeneca Ab | Methods of delaying pain progression and treating prostate cancer |
-
2023
- 2023-02-14 CN CN202380021612.6A patent/CN118829430A/zh active Pending
- 2023-02-14 US US18/837,956 patent/US20250134887A1/en active Pending
- 2023-02-14 EP EP23705969.6A patent/EP4479053A1/en active Pending
- 2023-02-14 WO PCT/EP2023/053555 patent/WO2023156357A1/en not_active Ceased
- 2023-02-14 IL IL314798A patent/IL314798A/en unknown
- 2023-02-14 MX MX2024009923A patent/MX2024009923A/es unknown
- 2023-02-14 JP JP2024547679A patent/JP2025505041A/ja not_active Withdrawn
- 2023-02-14 AU AU2023220646A patent/AU2023220646A1/en active Pending
- 2023-02-14 CA CA3250763A patent/CA3250763A1/en active Pending
- 2023-02-14 KR KR1020247030614A patent/KR20240148418A/ko not_active Withdrawn
- 2023-02-15 TW TW112105268A patent/TW202400267A/zh unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP6141958B2 (ja) | 増殖性疾患の治療のための併用療法（ベムラフェニブ及びｍｄｍ２阻害剤） | |
| Bahl et al. | Second-line treatment options in metastatic castration-resistant prostate cancer: a comparison of key trials with recently approved agents | |
| JP2019532051A5 (https=) | ||
| JP2007515469A5 (https=) | ||
| CN102770131A (zh) | 卡巴他赛的新颖抗肿瘤用途 | |
| JP2020516646A5 (https=) | ||
| JP2024527109A5 (https=) | ||
| JP2019526632A5 (https=) | ||
| JP2024502446A5 (https=) | ||
| JP2021509395A5 (https=) | ||
| WO2023100070A1 (en) | Cdk4 inhibitor for the treatment of cancer | |
| CN101687104A (zh) | 包括长春氟宁和曲妥单抗的癌症治疗联合疗法 | |
| TW202329946A (zh) | 用於治療癌症之方法及包含cdk2抑制劑之給藥方案 | |
| EP4005567A1 (en) | Isoflavonoid composition with improved pharmacokinetics | |
| JP2004525143A5 (https=) | ||
| JP2022543679A5 (https=) | ||
| JP2024538719A5 (https=) | ||
| JP2025505041A5 (https=) | ||
| JP2025509278A (ja) | 小細胞肺癌を治療する方法 | |
| JP2024540044A5 (https=) | ||
| CN116322690A (zh) | 组合的药物抗癌疗法 | |
| CN104968340A (zh) | 治疗肝脏疾病或病状的用途和方法 | |
| JP6549107B2 (ja) | がんの処置のための、ｒｏ５５０３７８１、カペシタビン及びオキサリプラチンの組み合わせ | |
| CN114340625B (zh) | 用雌激素受体-α抑制剂的口服剂型治疗癌症的方法 | |
| Iacovelli et al. | Abiraterone acetate in castration-resistant prostate cancer |